DNA methylation as an epigenetic biomarker in colorectal cancer

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1687-1692

  Donizetti Silva, Tiago ^a   Marques Vidigal, Veronica ^a   Vitor Felipe, Aledson ^a   Miranda De Lima, Jacqueline ^a   Artigiani Neto, Ricardo ^a   Sidney Saad, Sarhan ^a   Manoukian Forones, Nora ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Colorectal cancer; Epigenetics; Methylation

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HEPATOCYTE NUCLEAR FACTOR 1BETA; PROTEIN MLH1; SECRETED FRIZZLED RELATED PROTEIN 5; SOMATOMEDIN B; TRANSCRIPTION FACTOR RUNX3;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE REGULATION; CELL INVASION; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENE; HUMAN; HUMAN TISSUE; PCDH10 GENE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION;

EID: 84886787789     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1606     Document Type: Article

References (22)

1. INCA (2013). Instituto Nacional do Câncer. Ministério da Saúde. http://www.inca.gov.br/estimativa/2012/. Accessed January 10, 2013.
2. Kim MS, Lee J and Sidransky D: DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29: 181-206, 2010.
3. Pellegrini ML, Argibay P and Gómez DE: Genetics and epigenetics of colorectal cancer. Acta Gastroenterol Latinoam 41: 247-261, 2011 (In Spanish).
4. Toribara NW and Sleisenger MH: Screening for colorectal cancer. N Eng J Med 332: 861-867, 1995.
5. Winawer SJ: Colorectal cancer screening. Best Pract Res Clin Gastroenterol 21: 1031-1048, 2007.
6. Pignone MP and Lewis CL: Using quality improvement techniques to increase colon cancer screening. Am J Med 122: 419-420, 2009.
7. Atkin W: Options for screening for colorectal cancer. Scand J Gastroenterol Suppl 237: 13-16, 2003.
8. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704-2714, 2004.
9. Grützmann R, Molnar B, Pilarsky C, et al: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 3: e3759, 2008.
10. Grady WM and Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099, 2008.
11. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Eng J Med 319: 525-532, 1988.
12. Carmona FJ and Esteller M: Epigenomics of human colon cancer. Mutat Res 693: 53-60, 2010.
13. Rawson JB and Bapat B: Epigenetic biomarkers in colorectal cancer diagnostics. Expert Rev Mol Diagn 12: 499-509, 2012.
14. Conover WI: Practcal Nonparametric Statistics. 1st edition. John Wiley & Sons, Inc., New York, NY, USA, 1971.
15. Daniel WW and Cross CL: Biostatistics: a foundation for analysis in the health sciences. 6th edition. John Wiley, Georgia, USA, 1995.
16. Migheli F and Migliore L: Epigenetics of colorectal cancer. Clin Genet 81: 312-318, 2012.
17. Lange CP, Campan M, Hinoue T, et al: Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One 7: e50266, 2012.
18. Karpf AR and Jones DA: Reactivating the expression of methylation silenced genes in human cancer. Oncogene 21: 5496-5503, 2012.
19. Schuebel KE, Chen W, Cope L, et al: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723, 2007.
20. Lofton-Day C, Model F, Devos T, et al: DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54: 414-423, 2008.
21. Goel A and Boland CR: Epigenetics of colorectal cancer. Gastroenterology 143: 1442-1460, 2012.
22. Ausch C, Kim YH, Tsuchiya KD, et al: Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem 55: 1559-63, 2009.